Pfizer Ibrance Breast Cancer Drug Shows Promising Results During Clinical Trial Pfizer's breast cancer drug Ibrance shows encouraging results in clinical trials. The drug is far more effective in delaying breast cancer progression in comparison to other drugs. by Sumit Passary
Healthy Living/Wellness Vaccine Costs in Developing Countries Too High, Many Blame GSK, Pfizer by James Maynard
Healthy Living/Wellness Betting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatment by Rhodi Lee
Healthy Living/Wellness New Viagra ad taps women to convince men to buy the blue pill by Sumit Passary
Healthy Living/Wellness Pfizer drug Xalkori effective against rare lung cancer in clinical trial by Christian Bautista
Healthy Living/Wellness Pfizer's breast cancer drug Palbociclib slows down tumor growth, shows hope for advanced cases by Rhodi Lee
Healthy Living/Wellness New experimental cholesterol drug by Amgen may be better than Lipitor by Rhodi Lee
Healthy Living/Wellness Pfizer recalls antidepressant Effexor after wrong drug found in bottle by Pierre Dumont
Healthy Living/Wellness Gene mutation that can reduce risk of Type 2 diabetes gets drugmakers' attention by Rhodilee Jean Dolor
Healthy Living/Wellness Childhood infection vaccine Pfizer Prevnar 13 also good for helping elderly ward off pneumonia by Pierre Dumont